(2023) Clinical, Immunological, and Genetic Findings in Iranian Patients with MHC-II Deficiency: Confirmation of c.162delG RFXANK Founder Mutation in the Iranian Population. Journal of Clinical Immunology. p. 12. ISSN 0271-9142